Left main and multivessel disease

Find all the latest content on left main and multivessel disease published on this website.

The left main coronary artery provides the primary source of blood flow to the left ventricle. Diseases affecting the left main, by itself or in combination with multivessel disease, place the patient at significant risk for life-threatening cardiovascular events. Treatment requires an understanding of all available tools, devices and techniques, like those employed in invasive imaging and functional assessment, as well as taking into account underlying comorbidities such as diabetes. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks. Use the filters below to access PCRonline resources.

Filtered By
Left main and multivessel disease

416 results

Hemodynamic support during CTO PCI: to use it or not?

15 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 Clinical Case submissions focused on the use of hemodynamic support devices during percutaneous coronary interventions (PCI) for chronic total occlusions (CTO). Experts will present and discuss challenging cases where the use of devices like the Impella pump or pulsatile left...

Hemodynamic support during CTO PCI: to use it or not?

Has the 2023 ESC-EACTS guideline review on left main changed my practice?

15 May 2024 – From EuroPCR 2024

Watch this session if you wish to learn why the 2019 guidelines were revised, how to apply the updated recommendations in clinical settings through case examples, and the criteria for selecting patients with left main stenosis for PCI versus CABG.
The session includes detailed presentations on...

Has the 2023 ESC-EACTS guideline review on left main changed my practice

Randomised trials: substudies and extended follow-up - A quick update

15 May 2024 – From EuroPCR 2024

This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...

Randomised trials: substudies and extended follow-up - A quick update

Innovating techniques for the treatment of coronary artery disease

14 May 2024 – From EuroPCR 2024

This session showcases innovative techniques for the treatment of coronary artery disease, including minimum contrast PCI with guide extension catheter and IVUS co-registration, management of iatrogenic aortic dissection using 3D-hologram and computational fluid dynamics, a novel tunnelling technique for huge coronary bypass graft aneurysms, and a...

Innovating techniques for the treatment of coronary artery disease

Challenging scenarios in STEMI

14 May 2024 – From EuroPCR 2024

This session features selected clinical case submissions highlighting challenging scenarios in the management of STEMI (ST-Elevation Myocardial Infarction) patients. Participants will learn about complex cases, such as left main time bomb, coronary anomalies, simultaneous two-vessel acute coronary thrombosis, and mechanical complications. The session includes case presentations...

Challenging scenarios in STEMI

Complex PCI in multivessel disease

14 May 2024 – From EuroPCR 2024

This session features selected clinical case submissions focused on complex PCI (Percutaneous Coronary Intervention) in patients with multivessel disease. Participants will learn about various challenging cases, including navigating heart failure, three-vessel disease with functional mitral regurgitation, complete revascularization assisted by Impella, and end-stage refractory angina. The...

Complex PCI in multivessel disease

Management of patient with complex left main stenosis - LIVE case

14 May 2024 – From EuroPCR 2024

A 52-year-old male, with a history of STEMI treated by PPCI on RCA one month ago, presents with angina CCS 2 and severe, calcified stenosis in the LAD, CX, and distal left main. The treatment involved implanting 2 stents in the LAD after Rota preparation, followed...

Management of patient with complex left main stenosis - LIVE case

Heart team discussion for left main PCI

14 May 2024 – From EuroPCR 2024

This session focuses on the role of the heart team in the management of complex left main coronary artery disease. It presents three cases, each with a unique set of challenges, and facilitates a structured discussion with the audience to arrive at the optimal treatment strategy....

Heart team discussion for left main PCI

When using left ventricular support during PCI

14 May 2024 – From EuroPCR 2024

This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the use of left ventricular support devices, such as the Impella, during percutaneous coronary interventions. Attendees will have the opportunity to explore various scenarios, including the management of Impella impaction,...

When using left ventricular support during PCI

DCB PCI in restenosis and de novo lesions

14 May 2024 – From EuroPCR 2024

This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the use of drug-coated balloons (DCB) in the management of restenosis and de novo coronary lesions. Attendees will have the opportunity to explore various strategies, including the use of a...

DCB PCI in restenosis and de novo lesions